Navigation Links
WuXi PharmaTech Named a Top Ten Outsourcing Enterprise in China for Five Consecutive Years
Date:6/28/2012

SHANGHAI, June 28, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D services company with operations in China and the United States, announced that it has been selected as one of the Top Ten Outsourcing Enterprise in China for 2012 by China's Ministry of Commerce (MOC). The list was announced at China's Fifth Annual International Service Outsourcing Cooperation Conference, held in Nanjing on June 20, 2012. WuXi PharmaTech is the only life science R&D service company among the top ten outsourcing enterprises.

Because of its creative business model of serving life science R&D industry and contribution to China's life science industry, WuXi PharmaTech has been selected into the Top 10 list for five consecutive years since the selection was initiated in 2008 by MOC. Earlier in 2011, Dr. Ge Li, Chairman and CEO, was named a Top Ten Contributor to China's Outsourcing Industry.

"We are honored to be consistently recognized as a top outsourcing company in China," Dr. Li said. "This speaks volume for WuXi's service business model. As a leading life science R&D service company, we will strive to improve our capabilities and capacities to better serve our pharmaceutical, biotechnology and medical device customers and partners, to help bring new products into market sooner and more cost effectively to benefit patients in needs."

Issued annually by Council for International Investment Promotion (CCIIP), a non-profit organization under Ministry of Commerce, the Top Ten Outsourcing Chinese Enterprise List recognizes the best outsourcing enterprises in China that have achieved great business growth on a yearly basis.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.  WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit http://www.wuxiapptec.com or contact:

Aaron Shi (for the media)
Tel:   +86-21-5046-4362
Email: Aaron_Shi@wuxiapptec.com

Ronald Aldridge (for investors)
Tel:   +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com


'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech Announces Third-Quarter 2011 Results
2. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
3. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
4. Sequenom Named to NASDAQ Global Select Market
5. U of Toronto experiment named top breakthrough of 2011 by Physics World
6. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
7. Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine
8. Royals Batter Billy Butler Named Hutch Award Winner
9. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
10. Kimberly-Clarks Bob Stargel Named One of Savoy Magazines Top 100 Most Influential Blacks in Corporate America
11. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Franz ... Semantic Graph Database technology, today announced the availability of AllegroGraph 6, the leading ... the Cloudera Certified Technology Program (CCPT). AllegroGraph is the first Semantic ...
(Date:2/6/2016)... ... , ... The Center for Excellence in Education (CEE) will sponsor a Bite ... February 10, 2016. This Bite of Science session, hosted by the Smithsonian-Mason School ... Remount Road in Front Royal, VA from 5:00 p.m. to 8:00 p.m. The dinner ...
(Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
(Date:2/4/2016)... ... February 04, 2016 , ... Shimadzu Scientific ... LC-MS, host live demos and poster sessions, and present on the analysis of ... takes place March 6 to 10 at the Georgia World Congress Center in ...
Breaking Biology Technology:
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
(Date:1/22/2016)... 22, 2016 ... of the  "Global Behavioral Biometric Market ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ... Biometric Market 2016-2020"  report to their ... Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ...
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
Breaking Biology News(10 mins):